Drug Type Mesenchymal stem cell therapy |
Synonyms AmnioPul-02, PulmoStem |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
RegulationOrphan Drug (EU) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 2 | SE | 06 Apr 2022 | |
COVID-19 | Phase 2 | GB | 06 Apr 2022 | |
Lower Respiratory Tract Infections | Phase 1 | SE | 10 Oct 2022 | |
Idiopathic Pulmonary Fibrosis | Preclinical | SE | - | |
Primary Graft Dysfunction | Preclinical | SE | - |